IT startup launches software to encourage physician-family conversations about epilepsy
Digital Health Solutions’ newest module focuses on sudden unexpected death in epilepsy, or SUDEP
For Immediate Release
Jan 31, 2019
INDIANAPOLIS – Physicians can now be alerted to pediatric patients’ risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Digital Health Solutions LLC, founded by Dr. Stephen Downs, has created a module about SUDEP for its Child Health Improvement through Computer Automation, or CHICA, system. Families answer questions on an electronic tablet about several health topics, including epileptic seizures.
“For children who have seizures, CHICA asks follow-up questions about frequency, medication adherence and barriers to accessing care,” said Downs, who is the Jean and Jerry Bepko Professor of Pediatrics at the IU School of Medicine. “The program shares this information with the physician. It also makes a reminder, through the patient’s electronic health record, for the physician to discuss SUDEP with the family. The physician can document discussing SUDEP and provide computer-generated educational materials.”
Downs said the module was tested at Eskenazi Health clinics for two months, and results were reported at the 2018 American Epilepsy Society meeting. Prior to testing the SUDEP module launch, 75 families of children with an epilepsy diagnosis were interviewed. Twenty-two percent reported that their physician had discussed SUDEP with them, while 28 percent had not heard of it before.
“When we tested the SUDEP module, more than 2,300 children were screened for epilepsy, and 1.3 percent of families reported that patients were affected by epilepsy. Forty-seven percent of those patients had a seizure within the previous 12 months, which made them a high risk for SUDEP,” Downs said. “Physicians reported counseling in 61 percent of those cases and referred families to a neurologist in 16 percent of those cases. They also counseled on medication adherence in 11 percent of the cases.
“Multiple professional organizations recommend that clinicians seeing children with epilepsy advise families of the risk of SUDEP. This single intervention has been more effective by far than any other effort to date.”
About Indiana University Innovation and Commercialization Office
Indiana University ICO is tasked with the protection and commercialization of technology emanating from innovations by IU researchers. Since 1997, IU research has generated almost 3,200 inventions resulting in more than 4,800 global patent applications. These discoveries have generated more than $145 million in licensing and royalty income, including more than $115 million in funding for IU departments, labs and inventors.